Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Testosterone's muscle-building effects do not require its conversion to DHT.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

DHT, a testosterone byproduct, causes male pattern baldness.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Finasteride shows promise for female hair loss, but more research needed.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Ultraviolet rays damage hair, smoking may cause hair loss, and good nutrition is important for hair health, but genetics mainly decide hair thickness.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.